We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Diet Augmented with Microgreens Lowers Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 27 Dec 2016
Print article
Image: In an animal study, red cabbage microgreens helped lower LDL cholesterol (Photo courtesy of the American Chemical Society).
Image: In an animal study, red cabbage microgreens helped lower LDL cholesterol (Photo courtesy of the American Chemical Society).
A diet augmented with red cabbage microgreens countered weight gain in a line of obese mice and reduced levels of cardiovascular disease indicators such as low-density lipoprotein cholesterol (LDL-c).

A microgreen is a tiny vegetable green that is used both as a visual and flavor component or ingredient primarily in fine dining restaurants. Microgreens, which are smaller than “baby greens” and harvested later than “sprouts,” are produced from various kinds of vegetables, herbs, or other plants. They range in size from one to three inches in length including the stem and leaves. A microgreen has a single central stem, which has been cut just above the soil line during harvesting. It has fully developed cotyledon leaves and usually has one pair of very small, partially developed true leaves. The average crop-time for most microgreens is 10–14 days from seeding to harvest.

Since previous studies had shown that full-grown red cabbage could reduce excessive cholesterol, investigators at the U.S. Department of Agriculture (Beltsville, MD, USA) evaluated the possibility that red cabbage microgreens might have a similar or even greater effect than their larger counterparts.

The investigators used a rodent diet-induced obesity model to address this question. A population of 60 five-weeks old male C57BL/6NCr mice were randomly assigned to six feeding groups: (1) low-fat diet; (2) high-fat diet; (3) low-fat diet + red cabbage microgreens; (4) low-fat diet + mature red cabbage; (5) high-fat diet + red cabbage microgreens; (6) high-fat diet + mature red cabbage. The animals were maintained on their respective diets for eight weeks.

Results published in the December 7, 2016, issue of the Journal of Agricultural and Food Chemistry revealed that microgreen supplementation reversed high-fat diet induced weight gain. Moreover, supplementation with microgreens significantly lowered circulating LDL levels in animals fed the high-fat diet and reduced hepatic cholesterol ester, triacylglycerol levels, and expression of inflammatory cytokines in the liver.

Overall, the results suggested that microgreens could modulate weight gain and cholesterol metabolism and may protect against cardiovascular disease by lowering elevated cholesterol levels.

Related Links:
U.S. Department of Agriculture

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.